Results 211 to 220 of about 1,428,732 (361)

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea

, 2017
Do Young Kim, Kwang‐Hyub Han, Byungyool Jun, Tae Hyun Kim, Sohee Park, Thomas Ward, Samantha Webster, Phil McEwan   +7 more
openalex   +2 more sources

The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka Health Districts of the South West region of Cameroon: a three-year retrospective study

, 2019
Mathias Eyong Esum, Brenda Mbouamba Yankam, Seraphine Nkie Esemu, Che Henry Ngwa, Ngwayu Claude Nkfusai, Cho Sebastine Anye, Gilbert Karngong Nfor, Samuel Nambile Cumber   +7 more
openalex   +1 more source

Hepatitis C and autoimmune hepatitis [PDF]

Hepatology, 2000
openaire   +2 more sources

Data to Monitor Viral Hepatitis Elimination in the United States. [PDF]

Public Health Rep
Casillas SM, Hoots BE, Gupta N.
europepmc   +1 more source

Two-dimensional Blue Native/SDS-PAGE Analysis Reveals Heat Shock Protein Chaperone Machinery Involved in Hepatitis B Virus Production in HepG2.2.15 Cells [PDF]

, 2008
Kun Liu, Qian Lu, Jinglan Wang, Wenrui Li, Xinyu Deng, Xilin Chen, Wei Sun, Handong Wei, Xiaohong Qian, Ying Jiang, Fuchu He   +10 more
openalex   +1 more source

Hepatitis

American Journal of Public Health and the Nations Health, 1958
openaire   +3 more sources

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC

Hepatology, EarlyView., 2022
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu, Bingqing Xu, Xiaodong Wang, Wen‐Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, Wenhua You, Hua Sun, Xiaoxin Mu, Dongju Feng, Yun Chen   +11 more
wiley   +1 more source

Balancing act: Tapering mycophenolate mofetil in immune checkpoint inhibitor hepatitis-strategies, outcomes, and risks. [PDF]

World J Gastrointest Pharmacol Ther
Mujumdar S, Shaikh S, Chan SY, Yekula A, Weinberg DR, Ansari NS, Jerez Diaz D, McPherson SB, Levstik M, Moon AM, Twohig P.   +10 more
europepmc   +1 more source

Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs

, 2017
Dustin B. Stephens, April M. Young, Jennifer R. Havens   +2 more
openalex   +2 more sources

Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus [PDF]

, 2018
Kristina Nystrôm, Paulina H. Wanrooij, J. Waldenström, Ludmila Adamek, Sofia Brunet, Joanna Said, Staffan Nilsson, Megan Wind‐Rotolo, Kristoffer Hellstrand, Heléne Norder, Ka‐Wei Tang, Martin Lagging   +11 more
openalex   +1 more source